Spectrum seeks ROLONTIS approval for chemotherapy-induced neutropenia
US biotech company Spectrum Pharmaceuticals said that it has submitted a Biologics License Application (BLA) for ROLONTIS (eflapegrastim) to the
Continue readingCoverage of Global Pharma Industry News
US biotech company Spectrum Pharmaceuticals said that it has submitted a Biologics License Application (BLA) for ROLONTIS (eflapegrastim) to the
Continue readingPelmeg EU approval : The European Commission (EC) has approved German pharma company Mundipharma’s Pelmeg, a pegylated version of granulocyte-colony
Continue readingNivestym FDA approval : Pfizer has bagged approval from the US Food and Drug Administration (FDA) for Nivestym (filgrastim-aafi) –
Continue reading